Transplantation and Liver Surgery Clinic, Helsinki University Hospital
Welcome,         Profile    Billing    Logout  
 4 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Isoniemi, Helena
RAXO, NCT01531595 / 2011-003137-33: Study of Bevacizumab in Combination with Alternating XELIRI and XELOX in Metastatic Colorectal Cancer

Active, not recruiting
2
100
Europe
Bevacizumab plus alternating XELOX/XELIRI, Avastin (bevacizumab), Xeloda (capecitabine), irinotecan, oxaliplatin, XELIRI (capecitabine + irinotecan), XELOX (capecitabine + oxaliplatin)
Pia Osterlund
Metastatic Colorectal Cancer
12/25
12/25
NCT02784080: Donor Specific HLA Alloantibodies in Liver Transplantation

Active, not recruiting
N/A
858
Europe
HLA-alloantibodies exposure
Rigshospitalet, Denmark, Sahlgrenska University Hospital, Sweden, Karolinska Institutet, Helsinki University Central Hospital, Oslo University Hospital
Complication of Transplanted Liver
09/24
12/24
RAXO, NCT01531621 / 2011-003158-24: A Population-based Prospective Study of Metastatic Colorectal Cancer (CRC) Patients in Finland

Recruiting
N/A
1000
Europe
Biomarker sampling
Pia Osterlund
Metastatic Colorectal Cancer
12/25
12/25
Arola, Johanna
NCT02784080: Donor Specific HLA Alloantibodies in Liver Transplantation

Active, not recruiting
N/A
858
Europe
HLA-alloantibodies exposure
Rigshospitalet, Denmark, Sahlgrenska University Hospital, Sweden, Karolinska Institutet, Helsinki University Central Hospital, Oslo University Hospital
Complication of Transplanted Liver
09/24
12/24

Download Options